The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer

Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Aug 30, 2001

Keywords

ClinConnect Summary

Results of radiation given to patients with AIDS-related high-grade CNS lymphoma have been disappointing, with short survival times due to infection complications. However, complete response has been documented after radiation in some patients. High-dose MTX will be used to improve the possibility of a greater antineoplastic response than that obtained by radiation alone. Since the underlying immunodeficiency state is not affected by therapy directed against the lymphoma, patients are still prone to life-threatening opportunistic infections or relapse of lymphomatous disease within the CNS....

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• • Patient must have negative titers for toxoplasmosis or other infectious etiology for CNS disease.
• Prior Medication:
• Allowed:
• • Zidovudine may be continued per protocol specifications.
• • Exclusion Criteria
• • Pathologic diagnosis of lymphoma in central nervous system (CNS) must be confirmed but no previous treatment is allowed. In participating institutions where CNS biopsies cannot be obtained, the patient may be considered eligible if space-occupying lesions have been demonstrated on computerized tomography or magnetic resonance imaging with negative titers for toxoplasmosis or negative response to empiric therapy for intracerebral toxoplasmosis and negative workup for other infectious etiology of CNS disease.
• Co-existing Condition:
• Patients with the following are excluded:
• • Positive titers for toxoplasmosis. Positive titers for other infectious etiology of CNS disease. Acute intercurrent infection. A second active tumor other than nonmelanomatous skin cancer or Kaposi's sarcoma. Lymphomatous meningitis alone without a mass lesion in the brain.
• Concurrent Medication:
• Excluded:
• • Acetaminophen, nonsteroidal anti- inflammatory agents, and corticosteroids other than dexamethasone.
• Prior Medication:
• Excluded:
• • Acetaminophen, nonsteroidal anti-inflammatory agents, and corticosteroids other than dexamethasone.
• * Excluded within 2 weeks of study entry:
• • Immunomodulating agents.
• * Excluded within 30 days of study entry:
• • Any investigational agent.

Trial Officials